
|Videos|October 3, 2016
How Can Access to Costly Specialty Drugs be Improved?
Author(s)Lauren Santye, Assistant Editor
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Advertisement
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
2
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
3
Federal Health Officials Scale Back Number of Recommended Vaccines for Children
4
Former FDA Chief Scientist Jesse Goodman Breaks Down the Implications of Pediatric Vaccine Guideline Changes
5













































































































































































































